Accepted at 11:10 p.m. Mar, 20, 2024 by Ahmed7
Author: FrozenCherry
Related Note: 1479267502899
Rationale for change

cards sounds like DC is a special case of langerhans cells whereas card wants to convey that DC in the skin are Langerhans cells

actually card should be phrased as "langerhans cells are DC in the skin, more active structure rather than the current passive sentence structure"

Text Text
Extra

Photo credit: Haymanj, Public domain, via Wikimedia Commons
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid

Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Physeo
Empty field
OME

Additional Resources
Other:
One by one
Empty field
#AK_Step1_v12::#Bootcamp::Immunology::02_Innate_vs_Adaptive_Immunity::02_Adaptive_Immunity_and_Antigen_Presentation #AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Hematology_&_Oncology::RBC_Misc. #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::02_Blood_Cells::07_Monocyte_and_Macrophage #AK_Step1_v12::#FirstAid::10_Hematology_Oncology::04_Pathology::32_Langerhans_Cell_Histiocytosis::*Basics #AK_Step1_v12::#UWorld::COMLEX::23701 #AK_Step1_v12::#FirstAid::10_Hematology_Oncology::02_Anatomy::10_Dendritic_Cells !AK_UpdateTags::Step1decks::Zanki-Step-Decks::Zanki-Hematology-&-Oncology::RBC-Misc. #AK_Step1_v12::#Physeo::08_Immunology::01_Immunology::09_Cytokines_from_Macrophages_&_Dendritic_Cells #AK_Step1_v12::#Pathoma::06_WBC::09_Langerhans_Cell_Histiocytosis #AK_Step2_v12::#Resources_by_rotation::IM::ome::heme/onc::lymphoma #AK_Step1_v12::^Systems::HemeOnc::WBC #AK_Step1_v12::^Other::^HighYield::1-HighYield #AK_Step2_v12::#OME::01_Medicine::05_Hematology_Oncology::06_Lymphoma #AK_Step1_v12::#FirstAid::10_Hematology_Oncology::02_Anatomy::06_Macrophages::Specific_Tissues::Langerhans_Cells #AK_Step1_v12::#NBME::18 #AK_Step1_v12::#Pixorize::02_Immunology::03_Other_Cell_Types::09_Dendritic_Cells #AK_Step2_v12::!Shelf::IM::no_dupes #AK_Step1_v12::^Systems::HemeOnc::RBC::Anatomy #AK_Step1_v12::#Physeo::11_Pathology::10_HemeOnc_Pathology::14_Myeloproliferative_Disorders #AK_Step1_v12::#OME::PreClinical::Immunology #AK_Step1_v12::#Physeo::11_Pathology::10_HemeOnc_Pathology::19_Langerhans_Cell_Histiocytosis #AK_Step1_v12::#FirstAid::10_Hematology_Oncology::04_Pathology::32_Langerhans_Cell_Histiocytosis #AK_Step1_v12::#UWorld::Step::588